Publications

Expansion of clonal complex 258 KPC-2-producing Klebsiella pneumoniae in Latin American hospitals: Report of the SENTRY antimicrobial surveillance program. by Castanheira M, Costello AJ, Deshpande LM and Jones RN published in Antimicrob. Agents Chemother. 2012; 56 (3): 1668-1669

Susceptibility of Klebsiella spp. to colistin and polymyxin B: Results from the SENTRY Antimicrobial Surveillance Program (2006-2009). by Sader HS, Farrell DJ and Jones RN published in Int. J. Antimicrob. Agents. 2011; 37 (2): 174-175

Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009). by Pfaller MA, Moet GJ, Messer SA, Jones RN and Castanheira M published in J. Clin. Microbiol. 2011; 49 (1): 396-399

Echinocandin and triazole antifungal susceptibility profiles for Candida spp. Cryptococcus neoformans, and Aspergillus fumigatus: Application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009). by Pfaller MA, Castanheira M, Messer SA, Moet GJ, Jones RN published in Diagn. Microbiol. Infect. Dis. 2011; 69 (1): 45-50

Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007 by Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN and Mendes RE published in Antimicrob. Agents Chemother. 2011; 55 (3): 1274-1278

Surveillance of JNJ-Q2 activity tested against Staphylococcus aureus and beta-hemolytic streptococci as a component of the 2010 SENTRY antimicrobial surveillance program. by Farrell DJ, Liverman LC, Biedenbach DJ, Flamm RK and Jones RN published in Diagn. Microbiol. Infect. Dis. 2011; 71 (4): 415-420

Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: Results from the SENTRY Antimicrobial Surveillance Program (2006-2009) by Gales AC, Jones RN and Sader HS published in J. Antimicrob. Chemother. 2011; 66 (9): 2070-2074

Comparative activity of linezolid against respiratory tract infection isolates of Staphylococcus aureus: An 11 year report from the SENTRY Antimicrobial Surveillance Program. by Jones RN, Farrell DJ, Sader HS published in Int. J. Antimicrob. Agents 2011; 37 (6): 580-587

Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: Report from the SENTRY Antimicrobial Surveillance Programme (2007-09). by Castanheira M, Mendes RE, Woosley LN and Jones RN published in J. Antimicrob. Chemother. 2011; 66 (6): 1409-1411

Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: Report from the SENTRY Antimicrobial Surveillance Program (2008-2009). by Pfaller MA, Castanheira M, Messer SA, Moet GJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 2010; 68 (3): 278-283

Declining antimicrobial susceptibility of Streptococcus pneumoniae in the United States: Report from the SENTRY Antimicrobial Surveillance Program (1998-2009). by Jones RN, Sader HS, Moet GJ, Farrell DJ published in Diagn. Microbiol. Infect. Dis. 2010; 68 (3): 334-336

Potency of anidulafungin compared to nine other antifungal agents tested against Candida spp., Cryptococcus spp. and Aspergillus spp.: Results from the Global SENTRY Antimicrobial Surveillance Program (2008). by Messer SA, Jones RN, Moet GJ, Kirby JT and Castanheira M published in J. Clin. Microbiol. 2010; 48 (8): 2984-2987

First descriptions of bla_KPC in Raoultella spp. (R. planticola and R. ornithinolytica): Report from the SENTRY Antimicrobial Surveillance Program. by Castanheira M, Deshpande LM, DiPersio JR, Kang J, Weinstein MP and Jones RN published in J. Clin. Microb. 2009; 47 (12); 4129-4130

Development of a disk diffusion method for testing Moraxella catarrhalis susceptibility using Clinical and Laboratory Standards Institute methods: a SENTRY Antimicrobial Surveillance Program report. by Bell JM, Turnidge JD, Jones RN published in J. Clin. Microb. 2009; 47 (7): 2187-2193

Activity of contemporary antifungal agents, including the novel Echinocandin Anidulafungin, tested against Candida spp., Cryptococcus Spp., and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007) by Messer SA, Moet GJ, Kirby JT, and Jones RN published in J. Clin. Microbiol. 2009; 47(6):1942-1946

Dissemination of a bla_VIM-2-Carrying Integron Among Enterobacteriaceae species in Mexico: Report from the SENTRY Antimicrobial Surveillance Program. by Morfin-Otero R, Rodriguez-Nkoriega E, Desphande LM, Sader HS, Castanheira M published in Microbial. Drug Resistance. 2009; 15 (1): 33-35

Codetection of bla_OXA-23-like gene (bla_OXA-133) and bla_OXA-58 in Acintobacter radioresistens: Report from the SENTRY Antimicrobial Surveillance Program. by Mendes RE, Bell JM, Turnidge JD, Castanheira M, Deshpande LM and Jones RN published in Antimicrob. Agents Chemother. 2009; 53 (2): 843-844

Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemased among Acinetobacter spp. in Asia-Pacific nations: Report from the SENTRY Surveillance Program. by Mendes RE, Bell JM, Turnidge JD, Castanheira M, and Jones RN published in J. Antimicrob. Chemother. 2009; 63 (1): 55-59

Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: Results from the SENTRY Antimicrobial Surveillance Program (2005-2006). by Fritsche TR, Sader HS and Jones RN published in Diagn. Microbiol. Infect. Dis. 2008; 61 (1): 86-95

Antimicrobial activities of tigecycline and other broad spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program. by Castanheira M, Sader HS, Deshpande LM, Fritsche TR and Jones RN published in Antimicrob. Agents Chemother. 2008; 52 (2): 570-573

Comparative in vitro activity of daptomycin against gram-positive microorganisms: SENTRY Surveillance Program, Spain (2002-2006). by Loza E, Morosini MI, Pascual A, Tubau F, Alcala J, Linares J, Hernandez-Bello JR, Baquero F, Perea E, Martin R, Jones RN and Canton R published in Enferm. Infecc. Microbiol. Clin. 2008; 26 (8): 489-494

Emergence and clonal dissemination of OXA-24- and OXA-58-producing Acintobacter baumannii strains in Houston, Texas: Report from the SENTRY Antimicrobial Surveillance Program. by Castanheira M, Wanger A, Kruzel M, Deshpande LM and Jones RN published in J. Clin. Microbiol. 2008; 46 (9): 3179-3180

Antimicrobial susceptibility of Gram-negative bacilli isolated in Brazilian hospitals participating in the SENTRY Program (2003-2008). by Andrade S, Sader HS, Barth A, Ribeiro J, Zoccoli C, Pignatari AC and Gales AC published in Braz. J. Infect. Dis. 2008; 12 (Suppl. 2): S3-S9

Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin and teicoplanin: A SENTRY Program report (2003-2004). by Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN and Turnidge JD published in Int. J. Antimicrob. Agents 2007; 30 (2): 143-149

In71, an Enterobacter cloacae bla_VIM-1-carrying integron related to In70.2 from Italian Pseudomonas aeruginosa isolates: A SENTRY Antimicrobial Surveillance Program report. by Castanheira M, Sader HS, Jones RN, Debbia Eugenio, Picao RC and Gales AC published in Microb. Drug Resis. 2007; 13 (2): 130-134

Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: A report from the SENTRY Antimicrobial Surveillance Program. by Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 2007; 58: 163-170

Potency and spectrum of garenoxacin tested against an international collection of skin and skin tissue infection pathogens: Report from the SENTRY Antimicrobial Surveillance Program (1999-2004). by Fritsche TR, Sader HS and Jones RN published in Diagn. Microbiol. Infect. Dis. 2007; 58 (1): 19-26

Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test reslt for isolates of Escherichia coli and Klebsiella pneumoniae: Results from the SENTRY Asia-Pacific Surveillance Program. by Bell JM, Chitsaz M, Turnidge JD, Barton M, walters LJ and Jones RN published in J. Clin. Microbiol. 2007; 45 (5): 1478-1482

Activity of linezolid against 3,251 strains of uncommonly isolated Gram-positive organisms: Report from the SENTRY Antimicrobial Surveillance Program. by Jones RN, Stilwell MG, Hogan PA and Sheehan DJ published in Antimicrob. Agents Chemother. 2007; 51 (4): 1491-1493

Contemporary causes of skin and soft tissue infections in North America, Latin America and Europe: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004). by Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG and Fritsche TR published in Diagn. Microbiol. Infect. Dis. 2007; 57 (1): 7-13

Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004). by Jones RN, Sader HS, Fritsche TR and Pottumarthy S published in Diagn. Microbiol. Infect. Dis. 2007; 57 (1): 109-116

Activity of gatifloxacin tested against isolates from pediatric patients: Report from the SENTRY Antimicrobial Surveillance Program (North America, 1998-2003). by Fedler KA, Jones RN, Sader HS and Fritsche TR published in Diagn. Microbiol. Infect. Dis. 2006; 55 (2): 157-164

Microbiological and epidemiological characterization of imipenem-resistant Pseudomonas aeruginosa strains from a Brazilian tertiary hospital: Report from the SENTRY Antimicrobial Surveillance Program. by Ribeiro J, Mendes RE, Domingos R, Franca E, Silbert S, Jones RN and Sader HS published in J. Chemo. 2006; 18 (5): 461-467

Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: Report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents. by Fedler KA, Biedenbach DJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 56 (4): 427-436

Survey of bloodstream infection isolates: SENTRY Antimicrobial Surveillance Program in Buenos Aires, Argentina (1997-2002). by Vargas LJ, Casellas JM, Gales A, Tome A, Sader HS, Lanza A, Jones RN and Smayevsky J published in Rev. Panam. Infectol. 2006; 8 (3): 11-17

Contemporary prevalence of BRO β-lactamases in Moraxella catarrhalis: Report from the SENTRY Antimicrobial Surveillance Program (North America, 1997 to 2004). by Deshpande LM, Sader HS, Fritsche TR, and RN Jones published in J. Clin. Microbiol. 2006; 44 (10): 3775-3777

Emergence of multidrug-resistant Streptococcus pneumoniae: Report from the SENTRY Antimicrobial Surveillance Program (1999-2003). by Johnson DM, Stilwell MG, Fritsche TR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 56 (1): 69-74

International surveillance of Candida spp. and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2003). by Messer SA, Jones RN and Fritsche TR published in J. Clin. Microbiol. 2006; 44 (5): 1782-1787

Global assessment of the antimicrobial activity of polymyxin B against 54,731 clinical isolates of Gram-negative bacilli: Report from the SENTRY Antimicrobial Surveillance Programme (2001-2004). by Gales AC, Jones RN and Sader HS published in Clin. Microbiol. Infect. 2006; 12 (4): 315-321

Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: Report from the SENTRY Antimicrobial Surveillance Program. by Bhavnani SM, Ambrose PG, Craig WA, Dudley MN and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 54 (3): 231-236

Emergence and epidemiology for fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: Report from the SENTRY Antimicrobial Surveillance Program (2001-2004). by Deshpande LM, Sader HS, Debbia E, Nicoletti G, Fadda G and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 53 (3): 157-164

Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program (2000-2004). by Deshpande LM, Jones RN, Fritsche TR and Sader HS published in Microb. Drug Resist. 2006; 12 (4): 223-230

Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: Report from the Sentry Antimicrobial Surveillance Program (1997-2004). by Biedenbach DJ, Toleman M, Walsh TR, and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 54 (1): 13-21

Changing antimicrobial susceptibility patterns among Streptococcus pneumoniae and Haemophilus influenzae from Brazil: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004). by Castanheira M, Gales AC, Pignatari ACC, Jones RN and Sader HS published in Microb. Drug Resist. 2006; 12 (2): 91-98

Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin American and Salmonella isolates recovered from bloodstream infections in North America: Report from the SENTRY Antimicrobial Surveillance Program (2003). by Streit JM, Jones RN, Toleman MA, Stratchounski LS and Fritsche TR published in Int. J. Antimicrob. Agents 2006; 27 (5): 367-375

Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004). by Pfaller MA, Sader HS, Fritsche TR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 56 (1): 63-68

Occurrence of plasmidic AmpC type β-lactamase-mediated resistance in Escherichia coli: Report from the SENTRY Antimicrobial Surveillance Program (North America, 2004). by Deshpande LM, Jones RN, Fritsche TR and Sader HS published in Int. J. Antimicrob. Agents 2006; 28 (6): 578-581

Characterization of fluoroquinolone-resistant β-haemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: Report from the SENTRY Antimicrobial Surveillance Program (1997-2004). by Biedenbach DJ, Toleman MA, Walsh TR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 55 (2): 119-127

Comparative activity of oral and parenteral cephalosporins tested against multidrug-resistant Streptococcus pneumoniae: Report from the SENTRY Antimicrobial Surveillance Program (1997 – 2003). by Pottumarthy, S., Fritsche, T.R., Jones, R.N. published in Diagn. Microbiol. Infect. Dis. 2005; 51 (2): 147-150

Evolution and dissemination of extended-spectrum β-lactamase-producing Klebsiella pneumoniae: Epidemiology and molecular report from the SENTRY Antimicrobial Surveillance Program (1997 – 2003). by DiPersio JR, Deshpande LM, Biedenbach DJ, Toleman MA, Walsh TR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2005; 51 (1): 1-7